Alere Inc (ALR) 39.13 $ALR Research Reports Initiation

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Alere Inc (ALR) 39.13 $ALR

Research Reports Initiation on Medical Laboratories & Research Stocks -- Quest Diagnostics, Bruker, Organovo, and Alere
PR Newswire - Wed Aug 31, 7:00AM CDT
Stock-Callers.com draws investors' attention to these Medical Laboratories and Research equities: Quest Diagnostics Inc. (NYSE: DGX), Bruker Corp. (NASDAQ: BRKR), Organovo Holdings Inc. (NASDAQ: ONVO), and Alere Inc. (NYSE: ALR). Industry growth is influenced by a number of trends, which include demographics, emerging economies, biotech advances in genetics, and pathogen evolution. Learn more about these stocks by downloading their free report at: http://stock-callers.com/registration
ONVO: 3.87 (+0.08), DGX: 83.04 (+0.68), BRKR: 22.38 (-0.06), ALR: 39.13 (+0.69)

Stock Market News for August 29, 2016
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:10AM CDT
Benchmarks ended a choppy trading session mostly in the red on Friday as investors continued to grapple with the timing of a rate hike
ABT: 42.09 (-0.21), YHOO: 43.28 (+0.35), NEE: 123.13 (+2.13), TERP: 13.24 (+0.39), DUK: 80.24 (+0.91), FB: 126.51 (+0.34), SNP: 73.37 (+2.03), VFC: 60.03 (-1.53), ALR: 39.13 (+0.69)

Abbott Labs Sued by Alere over Pending $5.8B Acquisition
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:38AM CDT
Abbott Labs (ABT) was sued by Alere (ALR) in the latter's attempt to force the former to complete the $5.8 billion takeover.
ABT: 42.09 (-0.21), ANIP: 59.86 (-1.56), ALR: 39.13 (+0.69)

Alere Falls 2.43% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Aug 26, 1:15PM CDT
Alere (AMEX:ALR) traded in a range yesterday that spanned from a low of $38.80 to a high of $42.12. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $40.17 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ALR: 39.13 (+0.69)

Alere Issues Statement
PR Newswire - Fri Aug 26, 10:00AM CDT
Alere Inc. (NYSE: ALR) (the "Company" , a global leader in rapid diagnostic tests, today issued the following statement in response to inquiries from its shareholders:
ALR: 39.13 (+0.69)

Alere (ALR) Receives FDA Approval for RSV Molecular Test
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 7:16AM CDT
Alere recently announced 510(k) approval from the U.S. Food and Drug Administration (FDA) for its Alere i RSV test.
QDEL: 21.58 (-0.16), LNTH: 9.40 (-0.10), ALR: 39.13 (+0.69), NUVA: 66.74 (+0.68)

Alere (ALR) Reader Attains CE Mark, Submits Delayed 10K
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:08AM CDT
Alere Inc. (ALR) recently announced the receipt of In-Vitro Diagnostic (IVD) CE marking for its new Alere Reader.
BAX: 46.28 (+0.10), QDEL: 21.58 (-0.16), ALR: 39.13 (+0.69), NUVA: 66.74 (+0.68)

Upgrade Alert for Alere (ALR)
Comtex SmarTrend(R) - Wed Aug 10, 3:11AM CDT
Alere (AMEX:ALR) was upgraded from Neutral to Buy at BTIG today. The stock closed yesterday at $39.27 on volume of 1.0 million shares, below average daily volume of 1.9 million. Alere, Inc. offers patient diagnosis, monitoring and health management services. The Company produces consumer and professional medical diagnostic products, and remotely monitors patients for pre-eclampsia, and patients who are prescribed Warfarin for atrial fibrillation.
ALR: 39.13 (+0.69)

Alere Achieves IVD CE Mark for its Alere(TM) Reader Lateral Flow Assay Analyzer
PR Newswire - Tue Aug 09, 6:00AM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced it has achieved In-Vitro Diagnostic (IVD) CE marking in Europe for its new Alere(TM) Reader, a diagnostic analyzer that can be used in both point-of-care and laboratory settings. The Alere Reader will be initially available for use with the Alere BinaxNOW® Legionella and Streptococcus pneumoniae antigen cards, with other lateral flow applications and assays to follow.
ALR: 39.13 (+0.69)

SmarTrend Watching for Potential Pullback in Shares of Alere After 2.51% Gain
Comtex SmarTrend(R) - Mon Aug 08, 1:15PM CDT
Alere (AMEX:ALR) traded in a range yesterday that spanned from a low of $37.77 to a high of $40.68. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $37.52 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ALR: 39.13 (+0.69)

Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
PR Newswire - Mon Aug 08, 5:22AM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-K and reported its financial results for the fourth quarter and full year ended December 31, 2015.
ALR: 39.13 (+0.69)

Alere Opens New Diagnostics Manufacturing Facility in India
PR Newswire - Mon Aug 01, 3:15PM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced the opening of a state-of-the-art diagnostics manufacturing facility in Manesar, Haryana. The new factory will produce rapid tests for the detection of infectious diseases including Malaria, Dengue and HIV and export them across the Asia Pacific region, which is heavily impacted by these diseases.
ALR: 39.13 (+0.69)

Ford and Whole Foods skid, Alere and Facebook jump
AP - Thu Jul 28, 3:39PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Thursday:
BSX: 24.26 (-0.07), WFM: 30.78 (+0.22), F: 12.50 (+0.06), FB: 126.51 (+0.34), ALR: 39.13 (+0.69), GRPN: 5.36 (-0.03), MOH: 55.33 (+1.79)

Alere Comments on Pain Management Subpoena
PR Newswire - Wed Jul 27, 6:08PM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it received a U.S. Department of Justice subpoena addressed to Alere Toxicology Services, Inc. on July 1, 2016. The subpoena seeks records related to Medicare, Medicaid and Tricare billings dating back to 2010 for patient samples tested at the Company's Austin, Texas pain management laboratory. The Company is fully cooperating with the investigation.
ALR: 39.13 (+0.69)

Noteworthy Wednesday Option Activity: ALR, UNT, FORM
DividendChannel.com - Wed Jun 22, 2:28PM CDT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alere Inc. , where a total of 15,553 contracts have traded so far, representing approximately 1.6 million underlying shares.
ALR: 39.13 (+0.69)

GPM Reminds Investors of the June 20 Deadline in the Class Action Lawsuit Against Alere Inc.
BusinessWire - Mon Jun 20, 11:39AM CDT
Glancy Prongay & Murray LLP ("GPM" reminds investors of the June 20, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class" of investors who purchased Alere Inc. ("Alere" or the "Company" (NYSE: ALR) securities between May 9, 2013 and April 20, 2016, inclusive (the "Class Period" . Alere investors have until June 20, 2016 to file a lead plaintiff motion.
ALR: 39.13 (+0.69)

3-Day Deadline Alert: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Alere Inc. And Encourages Investors With Losses To Contact The Firm
ACCESSWIRE - Fri Jun 17, 6:01PM CDT
IRVINE, CA / ACCESSWIRE / June 17, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Alere Inc. ("Alere" or the "Company" (NYSE: ALR). Investors who purchased or otherwise acquired shares between May 9, 2013 and April 20, 2016, inclusive (the "Class Period" , are encouraged to contact the Firm prior to the June 20, 2016, lead plaintiff motion deadline.
ALR: 39.13 (+0.69)

DEADLINE ALERT, Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Alere, Inc. (ALR) and Lead Plaintiff Deadline: June 20, 2016
ACCESSWIRE - Fri Jun 17, 9:23AM CDT
NEW YORK, NY / ACCESSWIRE / June 17, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors of class action against Alere, Inc. ("Alere" or "the Company" (NYSE: ALR). The class action has been filed on behalf of a class consisting of all persons or entities who purchased Alere, Inc. securities during the period between May 9, 2013 and April 20, 2016 inclusive (the "Class Period" .
ALR: 39.13 (+0.69)

INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Alere Inc. and a Lead Plaintiff Deadline of June 20, 2016 - ALR
GlobeNewswire - Tue Jun 14, 10:27AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Alere Inc. (NYSE:ALR) securities between May 9, 2013 and April 20, 2016.
ALR: 39.13 (+0.69)

JUNE 20 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit Against Alere Inc. And Advises Investors With Losses To Contact The Firm
ACCESSWIRE - Fri Jun 10, 7:48PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 10, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Alere Inc. ("Alere" or the "Company" (NYSE: ALR) concerning possible violations of federal securities laws between May 9, 2013 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the June 20, 2016, lead plaintiff motion deadline.
ALR: 39.13 (+0.69)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 78

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading
Sabre Unveils AI Travel Tech: A Bold New Frontier

Updated Category News Views 49

Sabre's Game-Changing AI Travel Integration I'm no stranger to bold moves in the travel industry, but what Sabre's rolling out tomorrow might just be the biggest leap we've seen in a while. They're unleashing what's called the first global travel plug-in within Grok Bot, marking a significant shake-up in the travel tech sphere. Too many tech upgrades in this business...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 139

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 83

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 77

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
WHP Global's Japan Move: A Major Toy Market Play

Updated Category News Views 93

New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 63

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
Dawson Struggles With Q3 Losses Despite Growth Prospects

Updated Category News Views 110

Profit and loss dance around like a jittery stock, and Dawson Geophysical is feeling the heat this third quarter. Numbers are in, and we’re seeing a net loss of $5.2 million, translating to $0.17 per share—ouch. Not to mention a negative Adjusted EBITDA of $2 million. Compared to last year's hopes, that's a serious belly flop. Revenue Down, Hopes Up In a fetching...

Continue Reading
Crocs to Present at Key Industry Conferences

Updated Category News Views 69

Crocs Set to Step into the Spotlight Alright, if there's one thing about Crocs, Inc. (NASDAQ: CROX) that never fails to surprise, it's how they constantly keep everyone on their toes. The iconic casual footwear brand with its whimsical, love-it-or-hate-it reputation is strapping in for not one but two hefty conferences. They've circled November 19 and December 1, 2026, on...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 135

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading

Top 5 Most Recently Viewed Articles

Air Products Secures $140 Million in NASA Liquid Hydrogen Contracts

Updated Category News Views 85

Air Products Receives Significant NASA Contracts Air Products, a leading supplier in the industrial gases market, recently announced an impressive contract award from NASA valued at over $140 million. This contract aims at supplying liquid hydrogen for various NASA facilities, most notably the renowned Kennedy Space Center and other significant sites where vital space...

Continue Reading
Navigating Market Realities: A Look Ahead for Investors

Updated Category News Views 158

The Uncomfortable Truth About Market Valuations Many investors may feel uneasy hearing this, but it’s essential to face the real data regarding market potential. After analyzing the last 40 years of market information from various developed economies, including movements in China, the reality might deter those banking on robust returns in the forthcoming decade. There's...

Continue Reading
Sodexo Unveils Its Universal Registration Document for 2025

Updated Category News Views 367

Introduction to Sodexo's Fiscal 2025 Document Sodexo has made significant strides in enhancing transparency and providing essential information through its recently filed Fiscal 2025 Universal Registration Document (URD). This document, which is now accessible to investors and stakeholders, showcases the company's ongoing commitment to accountability and sustainability....

Continue Reading
Paratus Energy's Q4 2025 Results: Key Indicators to Analyze

Updated Category News Views 197

Paratus Energy Services Ltd. (PLSV) is about to drop its unaudited interim Q4 2025 financial results on February 27, 2026. But here’s the kicker—traders are left with scant intel leading into this call, and that can rattle markets. First off, let’s talk about the earnings whispers. The usual playbook includes scouring through EPS projections and revenue figures, but...

Continue Reading
Keefe Adjusts Rating for Bank of N.T. Butterfield Amid Challenges

Updated Category News Views 72

Keefe Downgrades the Bank of N.T. Butterfield Stock Rating Recently, Keefe, Bruyette & Woods revised its recommendation for Bank of N.T. Butterfield (NYSE: NTB) stock, shifting the rating from Outperform to Market Perform. The price target has also been adjusted from $44 to $41. This reflects the bank's forecast of significant net interest income (NII) challenges...

Continue Reading